Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
HEALWELL AI ( (TSE:AIDX) ) has provided an update.
HEALWELL AI has appointed Ian Kidson to its Board of Directors, bringing his extensive experience in financial, governance, and healthcare corporate leadership to the company. This strategic move is expected to bolster HEALWELL’s mission of advancing healthcare through early disease detection and improve its market positioning by leveraging Kidson’s expertise in guiding organizations through growth and transformation.
The most recent analyst rating on (TSE:AIDX) stock is a Hold with a C$0.94 price target. To see the full list of analyst forecasts on HEALWELL AI stock, see the TSE:AIDX Stock Forecast page.
Spark’s Take on TSE:AIDX Stock
According to Spark, TipRanks’ AI Analyst, TSE:AIDX is a Neutral.
HEALWELL AI’s overall score is driven by strong revenue growth and strategic corporate actions. However, significant challenges in profitability, cash flow, and technical indicators weigh heavily on the stock’s potential.
To see Spark’s full report on TSE:AIDX stock, click here.
More about HEALWELL AI
HEALWELL AI is a healthcare artificial intelligence company focused on preventative care. The company aims to improve healthcare and save lives through early identification and detection of diseases. It develops and commercializes advanced clinical decision support systems to help healthcare providers detect rare and chronic diseases, improve practice efficiency, and enhance patient health outcomes. HEALWELL is publicly traded on the Toronto Stock Exchange under the symbol ‘AIDX’ and on the OTC Exchange under ‘HWAIF’.
Average Trading Volume: 462,097
Technical Sentiment Signal: Sell
Current Market Cap: C$296.1M
Learn more about AIDX stock on TipRanks’ Stock Analysis page.